Clinical Trial Update: A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated whether famotidine or omeprazole alters the pharmacokinetics of raltegravir in HIV-infected patients; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• PRILOSEC (Omeprazole magnesium)
• Pepcid (famotidine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV-1 Infection, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2010-05-28